Cwikiel J, Fagerland MW, Wachtell K, Arnesen H, Seljeflot I, Flaa A (2022)
Exercise-induced change in circulating NT-proBNP could not distinguish between patients with and without coronary artery disease: the CADENCE study
Scand Cardiovasc J, 56 (1), 107-113
DOI 10.1080/14017431.2022.2075562, PubMed 35593516

Huse C, Anstensrud AK, Michelsen AE, Ueland T, Broch K, Woxholt S, Yang K, Sharma K, Tøllefsen IM, Bendz B, Amundsen BH, Damås JK, Berg ES, Bjørkelund E, Quiles-Jiménez A, Bjerkeli V, Bendz C, Kleveland O, Stensaeth KH, Opdahl A, Kløw NE, Andersen GØ, Wiseth R, Halvorsen B, Gullestad L et al. (2022)
Interleukin-6 inhibition in ST-elevation myocardial infarction: Immune cell profile in the randomised ASSAIL-MI trial
EBioMedicine, 80, 104013 (in press)
DOI 10.1016/j.ebiom.2022.104013, PubMed 35504178

Kluge KE, Seljeflot I, Arnesen H, Jensen T, Halvorsen S, Helseth R (2022)
Coagulation factors XI and XII as possible targets for anticoagulant therapy
Thromb Res, 214, 53-62
DOI 10.1016/j.thromres.2022.04.013, PubMed 35490644